Magnesium citrate
Magnesium citrate is a saline osmotic laxative used for bowel evacuation, including preparation of the bowel before endoscopic or radiological procedures.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Poorly absorbed magnesium ions exert an osmotic effect that draws water into the bowel lumen, increasing intraluminal volume and stimulating colonic motility to produce evacuation.
Prescribing in practice
- It is contraindicated in intestinal obstruction and should be avoided or used with great caution in significant renal impairment, where reduced excretion risks hypermagnesaemia.
- Ensure adequate hydration, as the purgative fluid losses can precipitate dehydration and electrolyte disturbance, particularly in elderly patients.
- Magnesium can chelate or reduce absorption of certain co-administered drugs, so the timing of other oral medicines may need separation.
Monitoring
Monitor renal function and consider serum magnesium in patients with impaired kidney function or when repeated doses are given.
Counselling the patient
- Drink plenty of clear fluid while the medicine works to avoid becoming dehydrated.
- Tell your prescriber if you have kidney problems before taking it.
- Effects come on quickly, so remain close to a toilet.
Evidence & guidelines
Magnesium salts are long-established osmotic laxatives, and current prescribing references caution against their use in renal impairment because of hypermagnesaemia risk.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Harvey-Bradshaw Index for Crohn's Disease · Inflammatory Bowel Disease
- Mayo Score for Ulcerative Colitis Activity · Inflammatory Bowel Disease
- Rome IV Criteria for Irritable Bowel Syndrome · Functional GI
- Crohn's Disease Activity Index (CDAI) · Inflammatory Bowel Disease
- Truelove and Witts Severity Index for Ulcerative Colitis · Inflammatory Bowel Disease
- Ulcerative Colitis Endoscopic Index of Severity (UCEIS) · Inflammatory Bowel Disease
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021